Correlation Between Inmax Holding and Handa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Inmax Holding and Handa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inmax Holding and Handa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inmax Holding Co and Handa Pharmaceuticals, you can compare the effects of market volatilities on Inmax Holding and Handa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inmax Holding with a short position of Handa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inmax Holding and Handa Pharmaceuticals.

Diversification Opportunities for Inmax Holding and Handa Pharmaceuticals

-0.41

Correlation Coefficient

Inmax Holding  Handa Pharmaceuticals

Very good diversification

The 3 months correlation between Inmax and Handa is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Inmax Holding Co and Handa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Handa Pharmaceuticals and Inmax Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inmax Holding Co are associated (or correlated) with Handa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Handa Pharmaceuticals has no effect on the direction of Inmax Holding i.e., Inmax Holding and Handa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Inmax Holding and Handa Pharmaceuticals

Assuming the 90 days trading horizon Inmax Holding Co is expected to generate 1.42 times more return on investment than Handa Pharmaceuticals. However, Inmax Holding is 1.42 times more volatile than Handa Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Handa Pharmaceuticals is currently generating about -0.26 per unit of risk. If you would invest  5,020  in Inmax Holding Co on September 16, 2024 and sell it today you would earn a total of  460.00  from holding Inmax Holding Co or generate 9.16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Inmax Holding Co  vs.  Handa Pharmaceuticals

Inmax Holding

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Inmax Holding Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Inmax Holding may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Handa Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Handa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Inmax Holding and Handa Pharmaceuticals

The main advantage of trading using opposite Inmax Holding and Handa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inmax Holding position performs unexpectedly, Handa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Handa Pharmaceuticals will offset losses from the drop in Handa Pharmaceuticals' long position.

The idea behind Inmax Holding Co and Handa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.